To determine the long-term survival outcome of subjects who had various PSA levels at screening
Study Type
OBSERVATIONAL
Enrollment
27,741
National Taiwan University Hospital
Taipei, Taiwan
Diagnosis of prostate cancer
Time frame: 20 years (average)
Cancer-specific death
Time frame: 20 years (average)
Overall survival
Time frame: 20 years (average)
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.